Chemours(CC) - 2023 Q3 - Earnings Call Presentation

Adjusted EBITDA 2023 Guidance – Update of Earnings and Cash Metrics Adjusted Free Cash Flow guidance reflects ~$400 million in capital expenditures, re-affirming our commitment to sustainability-led growth in TSS and APM Core drivers of capital expenditures are attributed to the following o ~$200 million of growth capex (TSS: Opteon™ expansion; APM: Nafion™ expansion, semicon PFA expansion) o ~$200 million of run and maintain and sustainability capex 1 Subject to risks, uncertainties and assumptions, all of ...